|
|
Article: Sanofi-Aventis Sues Novopharm for Patent Infringement in Canada.
- Article from:
- PR Newswire
- Article date:
- March 11, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sanofi-aventis has learned through the Canadian Ministry of Health website that Novopharm Limited has obtained marketing approval in Canada for a product claiming to be generic enoxaparin.
Sanofi-aventis companies Aventis Pharma Inc. and Aventis Pharma S.A. are bringing suit in the Federal Court against Novopharm for patent infringement of Canadian patent 2045433, which covers Lovenox(R).
Sanofi-aventis will vigorously defend its legal rights with respect to this patent.
About sanofi-aventis
Sanofi-Aventis is the world's 3rd largest pharmaceutical company, ranking number 1 in Europe. Backed by a world-class R&D organization, ...